Abstract
BackgroundSerological biomarkers with ability to predict outcome and therapeutic response of patients might be helpful in introducing the concept of treat-to-target into management of juvenile idiopathic arthritis (JIA). Among others,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
